EUR/USD 1.19182
0.199%
Gold 5061.24
0.716%
Oil 64.632
0.940%
USD/JPY 153.156
-0.795%
GBP/USD 1.36966
0.403%
GBP/JPY 209.773
-0.389%
Browse More
  • English
  • 简体中文
  • 繁體中文
  • Tiếng Việt
  • ไทย
  • Indonesia
Subscribe
Real-time News
February 11th - The National Health Commission and 11 other departments jointly issued the "Administrative Measures for the National Essential Medicines List" today. Compared with the previous document, the "Administrative Measures for the National Essential Medicines List" clarifies that adjustments to the types and quantities of essential medicines will be made based on changes in disease patterns, clinical application practices, changes in drug standards, and new drug launches, adhering to the principles of giving equal importance to traditional Chinese and Western medicine and prioritizing clinical application. It also comprehensively considers factors such as my countrys basic medical and health service needs, basic medical security levels, and drug supply security. The measures standardize the dynamic adjustment mechanism, strengthen the functional positioning of essential medicines, adhere to regular evaluation and dynamic management, and stipulate that the adjustment cycle should generally not exceed three years, with adjustments possible as needed.February 11th - The National Health Commission and 11 other departments jointly issued the "Administrative Measures for the National Essential Medicines List" today. Compared with the previous document, the "Administrative Measures for the National Essential Medicines List" adds legal and policy basis. It adds the "Basic Medical and Health Care and Health Promotion Law," the "Drug Administration Law," and other higher-level laws as legal basis, and aligns with policies such as the "Opinions of the General Office of the State Council on Improving the National Essential Medicines System" and the "Opinions of the General Office of the State Council on Further Improving the Supply and Price Stabilization of Shortage Drugs." The list structure is rationally optimized. National essential medicines are divided into chemical drugs and biological products, and traditional Chinese medicine (processed medicinal herbs and prepared Chinese medicines). Chemical drugs and biological products are mainly classified according to clinical pharmacology, while prepared Chinese medicines are mainly classified according to function.February 11th - The Peoples Bank of China released its 2025 financial market operation report. In 2025, the amount of commercial bill acceptances reached 42.7 trillion yuan, and the amount of discounting reached 33.9 trillion yuan. As of the end of 2025, the outstanding balance of commercial bill acceptances was 21.2 trillion yuan, an increase of 7.2% compared to the end of 2024; the outstanding balance of discounting was 16.5 trillion yuan, an increase of 11.2% compared to the end of 2024.The Russian Foreign Ministry stated that if the United States complies with the quantity limits of the New START Treaty, Russias position of suspending its actions that exceed the treatys limits will remain unchanged.On February 11, the State Administration for Market Regulation released the newly revised "Measures for the Administration of Food Recalls." Compared with the current measures, the new measures strengthen the primary responsibility of food producers and operators. They explicitly require food producers and operators to establish and implement a food recall management system, and stipulate that food operators, operators of centralized food trading markets, lessors of food stalls, organizers of food exhibitions, and third-party online food trading platform providers have an obligation to cooperate with recalls.

Prior to the release of Australian employment data, the AUD/JPY pair attempts to regain 89.00

Alina Haynes

Apr 12, 2023 13:44

 AUD:JPY.png

 

The AUD/JPY pair attempts to reclaim the critical resistance level of 89.00 during the Asian session. Kazuo Ueda, the governor of the Bank of Japan (BoJ), has advocated for an extension of the already decade-long ultra-loose monetary policy in order to consistently achieve an inflation rate above 2%.

 

The decelerating Producer Price Index (PPI) contradicts the optimistic outlook of the Japanese government regarding wage growth. As expected by market participants, the March PPI did not change. The annual PPI came in at 7.2%, which was higher than the consensus estimate of 7.1% but lower than the previous release of 8.1%. The inability of companies to sustain accelerating production rates at factory gates is indicative of weak household demand.

 

Analysts at Commerzbank anticipate that the Japanese Yen will only appreciate over the long term if the current monetary policy is abandoned quickly.

 

Regarding the Bank of Japan's (BoJ) Yield Curve Control (YCC), the IMF has stated that allowing more flexibility in YCC could have repercussions for global markets, but it could also prevent future policy shifts that could result in significant spillovers.

 

Investors are awaiting the March Employment Report for fresh impetus in the Australian Dollar. The market expects the Australian economy to add 20,000 employment, which is less than the previous estimate of 64.6K. While the Unemployment Rate is expected to rise to 3.6% from 3.5% in February, it is anticipated that the Unemployment Rate will increase to 3.6%.

 

Governor Philip Lowe of the Reserve Bank of Australia (RBA) has left the door open for additional rate hikes if Australian inflation persists, so the publication of stronger-than-expected employment gains could reignite fears of additional rate hikes.

Suggestion